HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
The purpose of this initiative is to: (1) support the efforts by R15-eligible Principal Investigators (PIs) to conduct rigorous basic and/or mechanistic pain research projects; (2) promote integrated, interdisciplinary research partnerships between R15-eligible PIs and additional investigators from U.S. domestic institutions, and (3) enhance the pain research environment at the R15-eligible institution for health professional trainees or undergraduate and/or graduate students by actively engaging them in the proposed pain research projects.
Last confirmed Oct 13, 2026 · Grants.gov
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional): Eligibility, Deadline, and Award Questions
Who is eligible for HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)?
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) eligibility includes eligible applicants named in the notice. Geographic eligibility is national or notice-specific geography; applicants should confirm the source notice before applying.
What is the deadline for HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)?
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) has a listed deadline of November 23, 2026. Grant deadlines can change, so verify the current date with National Institutes of Health before submitting.
How much funding is available for HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)?
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) lists an award size of not disclosed. Award ranges and total program funding are reported from the source metadata when available.
Who funds HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)?
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) is funded by National Institutes of Health. GrantSonar tracks the notice with source ID 358090 from grants_gov.
Eligibility facets
Not listed in source metadata.
Not restricted in source metadata, or listed in the full notice.
Not disclosed in source metadata.
Grants.gov · 358090
Check whether this grant fits your organization
GrantSonar compares the notice against your mission, geography, eligibility, and programs before you spend time writing.